These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26933345)

  • 1. Feasibility and efficacy of thrombolysis in acute ischemic stroke: A study from National Institute of Neurological and Allied Sciences, Kathmandu, Nepal.
    Thapa L; Shrestha S; Shrestha P; Bhattarai S; Gongal DN; Devkota UP
    J Neurosci Rural Pract; 2016; 7(1):55-60. PubMed ID: 26933345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraarterial thrombolytic therapy within 3 hours of the onset of stroke.
    Bourekas EC; Slivka AP; Shah R; Sunshine J; Suarez JI
    Neurosurgery; 2004 Jan; 54(1):39-44; discussion 44-6. PubMed ID: 14683539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
    Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of prehospital delay and intravenous thrombolysis in the management of acute ischemic stroke in Nepal.
    Nepal G; Yadav JK; Basnet B; Shrestha TM; Kharel G; Ojha R
    BMC Neurol; 2019 Jul; 19(1):155. PubMed ID: 31288770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous thrombolysis for acute ischemic stroke occurring during hospitalization for transient ischemic attack.
    Tsivgoulis G; Sharma VK; Mikulik R; Krogias C; Haršány M; Bavarsad Shahripour R; Athanasiadis D; Teoh HL; Piperidou C; Alexandrov AV
    Int J Stroke; 2014 Jun; 9(4):413-8. PubMed ID: 23981541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India.
    Boddu DB; Srinivasarao Bandaru VC; Reddy PG; Madhusudan M; Rukmini MK; Suryaprabha T; Jabeen SA; Suvarna A; Jayalakshmi SS; Meena AK; Borgohain R; Kaul S
    Neurol India; 2010; 58(3):403-6. PubMed ID: 20644268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Thrombolytic Therapy for Stroke with Unknown Time of Onset: A Meta-Analysis of Observational Studies.
    Zhu RL; Xu J; Xie CJ; Hu Y; Wang K
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104742. PubMed ID: 32127258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of thrombolysis in patients aged 80 years or above with major acute ischemic stroke.
    Kim SC; Hong KS; Cho YJ; Cho JY; Park HK; Song P
    Neurol India; 2012; 60(4):373-8. PubMed ID: 22954971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute combined revascularization in acute ischemic stroke with intracranial arterial occlusion: self-expanding solitaire stent during intravenous thrombolysis.
    Šaňák D; Köcher M; Veverka T; Černá M; Král M; Buřval S; Školoudík D; Prášil V; Zapletalová J; Herzig R; Kaňovský P
    J Vasc Interv Radiol; 2013 Sep; 24(9):1273-9. PubMed ID: 23973019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
    Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of acute ischemic stroke after intra-arterial thrombolysis: A study from India.
    Chaudhuri JR; Kumar R; Umamahesh M; Mridula KR; Alladi S; Bandaru S
    Iran J Neurol; 2016 Oct; 15(4):195-201. PubMed ID: 28435627
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of prehospital intervention based on emergency medical services on door-to-needle time of thrombolysis in acute ischemic stroke].
    Wang Y; Zhang C; Sun W; Hu X; Lyu Z; Liu W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):667-670. PubMed ID: 30045795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Thrombolysis Administration 3-4.5 h After Acute Ischemic Stroke: A Retrospective, Multicenter Study.
    Chen YW; Sung SF; Chen CH; Tang SC; Tsai LK; Lin HJ; Huang HY; Po HL; Sun Y; Chen PL; Chan L; Wei CY; Lee JT; Hsieh CY; Lin YY; Yeh SJ; Lien LM; Jeng JS
    Front Neurol; 2019; 10():1038. PubMed ID: 31681138
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator.
    Huang YH; Zhuo ST; Chen YF; Li MM; Lin YY; Yang ML; Chen ZJ; Cai RW
    Chin Med J (Engl); 2013; 126(24):4685-90. PubMed ID: 24342312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.